| Style | Citing Format |
|---|---|
| MLA | Dousti M, et al.. "Investigation of the Prevalence of Cryptosporidium Parvum Among Hiv-Positive Individuals With Recombinant Cp2 and Cp23 Antigens." Journal of Parasitic Diseases, vol. , no. , 2026, pp. -. |
| APA | Dousti M, Amshawee AM, Ahmed Alsaeed M, Almamorri I, Jasim YH, Hussain MA, Nasiri M, Asl FSS, Barezgar G (2026). Investigation of the Prevalence of Cryptosporidium Parvum Among Hiv-Positive Individuals With Recombinant Cp2 and Cp23 Antigens. Journal of Parasitic Diseases, (), -. |
| Chicago | Dousti M, Amshawee AM, Ahmed Alsaeed M, Almamorri I, Jasim YH, Hussain MA, Nasiri M, Asl FSS, Barezgar G. "Investigation of the Prevalence of Cryptosporidium Parvum Among Hiv-Positive Individuals With Recombinant Cp2 and Cp23 Antigens." Journal of Parasitic Diseases , no. (2026): -. |
| Harvard | Dousti M et al. (2026) 'Investigation of the Prevalence of Cryptosporidium Parvum Among Hiv-Positive Individuals With Recombinant Cp2 and Cp23 Antigens', Journal of Parasitic Diseases, (), pp. -. |
| Vancouver | Dousti M, Amshawee AM, Ahmed Alsaeed M, Almamorri I, Jasim YH, Hussain MA, et al.. Investigation of the Prevalence of Cryptosporidium Parvum Among Hiv-Positive Individuals With Recombinant Cp2 and Cp23 Antigens. Journal of Parasitic Diseases. 2026;():-. |
| BibTex | @article{ author = {Dousti M and Amshawee AM and Ahmed Alsaeed M and Almamorri I and Jasim YH and Hussain MA and Nasiri M and Asl FSS and Barezgar G}, title = {Investigation of the Prevalence of Cryptosporidium Parvum Among Hiv-Positive Individuals With Recombinant Cp2 and Cp23 Antigens}, journal = {Journal of Parasitic Diseases}, volume = {}, number = {}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Dousti M AU - Amshawee AM AU - Ahmed Alsaeed M AU - Almamorri I AU - Jasim YH AU - Hussain MA AU - Nasiri M AU - Asl FSS AU - Barezgar G TI - Investigation of the Prevalence of Cryptosporidium Parvum Among Hiv-Positive Individuals With Recombinant Cp2 and Cp23 Antigens JO - Journal of Parasitic Diseases VL - IS - SP - EP - PY - 2026 ER - |